SG48115A1 - Inhibition of retrovirus infection - Google Patents

Inhibition of retrovirus infection

Info

Publication number
SG48115A1
SG48115A1 SG1996007118A SG1996007118A SG48115A1 SG 48115 A1 SG48115 A1 SG 48115A1 SG 1996007118 A SG1996007118 A SG 1996007118A SG 1996007118 A SG1996007118 A SG 1996007118A SG 48115 A1 SG48115 A1 SG 48115A1
Authority
SG
Singapore
Prior art keywords
inhibition
retrovirus infection
slpi
prevention
methods
Prior art date
Application number
SG1996007118A
Other languages
English (en)
Inventor
Robert C Thomson
Sharon M Wahl
Stephen Eisenberg
Amgen Boulder
Original Assignee
Amgen Boulder Inc
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Boulder Inc, Us Health filed Critical Amgen Boulder Inc
Publication of SG48115A1 publication Critical patent/SG48115A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
SG1996007118A 1992-09-09 1993-09-09 Inhibition of retrovirus infection SG48115A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94336992A 1992-09-09 1992-09-09

Publications (1)

Publication Number Publication Date
SG48115A1 true SG48115A1 (en) 1998-04-17

Family

ID=25479533

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007118A SG48115A1 (en) 1992-09-09 1993-09-09 Inhibition of retrovirus infection

Country Status (23)

Country Link
EP (1) EP0666755B1 (pt)
JP (2) JP3517238B2 (pt)
KR (1) KR100273620B1 (pt)
AT (1) ATE238062T1 (pt)
AU (1) AU681350B2 (pt)
CA (1) CA2141951C (pt)
CZ (1) CZ286953B6 (pt)
DE (1) DE69332904T2 (pt)
DK (1) DK0666755T3 (pt)
ES (1) ES2197153T3 (pt)
FI (1) FI951078A (pt)
HU (1) HU218892B (pt)
NO (1) NO315546B1 (pt)
NZ (1) NZ256246A (pt)
OA (1) OA10133A (pt)
PL (1) PL307864A1 (pt)
PT (1) PT666755E (pt)
RO (1) RO116164B1 (pt)
RU (1) RU2126266C1 (pt)
SG (1) SG48115A1 (pt)
SK (1) SK281127B6 (pt)
UA (1) UA41338C2 (pt)
WO (1) WO1994006454A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ265896A3 (en) * 1994-03-23 1997-06-11 Tokyo Tanabe Co Tryptase inhibitor, its use and pharmaceutical compositions containing thereof
WO1997003694A1 (fr) * 1995-07-24 1997-02-06 Tokyo Tanabe Company Limited Remede contre les affections virales
CA2235394A1 (en) 1995-11-13 1997-05-22 Gerard Voerman Anti-viral isolates obtainable from leeches
DK1176193T3 (da) * 1999-05-13 2012-09-10 Japan Science & Tech Agency Hæmmere af virusinfektion, som angriber den n-terminale region af integrase
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
US8288439B2 (en) 2003-11-04 2012-10-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for the inhibition of HIV-1 replication

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2007083A1 (en) * 1989-01-09 1990-07-09 Nobuhiko Katunuma Pharmaceutical use of trypstatin
ES2097766T3 (es) * 1989-08-16 1997-04-16 Chiron Corp Composiciones para la inhibicion de la formacion de hormonas proteicas y sus usos.
CA2071972A1 (fr) * 1989-12-18 1991-06-19 Bruno Guy Composition pharmaceutique destinee au traitement ou a la prevention des infections retrovirales
GR1001044B (el) * 1991-06-03 1993-04-28 Logothetou Rella Eleni Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

Also Published As

Publication number Publication date
KR100273620B1 (ko) 2000-12-15
OA10133A (en) 1996-12-18
DK0666755T3 (da) 2003-08-04
RU95109909A (ru) 1997-03-27
NZ256246A (en) 1997-08-22
WO1994006454A2 (en) 1994-03-31
ES2197153T3 (es) 2004-01-01
CA2141951C (en) 2007-04-24
SK281127B6 (sk) 2000-12-11
DE69332904D1 (de) 2003-05-28
KR950703357A (ko) 1995-09-20
RO116164B1 (ro) 2000-11-30
CZ286953B6 (en) 2000-08-16
CZ55995A3 (en) 1996-01-17
JP2004002455A (ja) 2004-01-08
AU4853093A (en) 1994-04-12
FI951078A0 (fi) 1995-03-08
SK29795A3 (en) 1997-02-05
NO950897L (no) 1995-03-08
HU9500682D0 (en) 1995-04-28
PL307864A1 (en) 1995-06-26
HUT75126A (en) 1997-04-28
EP0666755A1 (en) 1995-08-16
UA41338C2 (uk) 2001-09-17
EP0666755B1 (en) 2003-04-23
CA2141951A1 (en) 1994-03-31
RU2126266C1 (ru) 1999-02-20
NO950897D0 (no) 1995-03-08
WO1994006454A3 (en) 1994-08-18
JP3517238B2 (ja) 2004-04-12
PT666755E (pt) 2003-09-30
FI951078A (fi) 1995-03-08
AU681350B2 (en) 1997-08-28
JPH08505042A (ja) 1996-06-04
HU218892B (hu) 2000-12-28
NO315546B1 (no) 2003-09-22
DE69332904T2 (de) 2003-11-06
ATE238062T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MX9706947A (es) Inhibidores de proteasa retroviral de sulfonilalcanoilamino-hidroxietilamino-sulfonamida y uso de los mismos.
PL322784A1 (en) Amino acid hydroxyethylaminosulphonamides as inhibitors of retroviral protease
AU5417896A (en) Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
AP9200410A0 (en) Retroviral protease inhibitors.
AU8125694A (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
MD960172A (en) 5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
HU9500682D0 (en) Inhibition of retrovirus infection
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
MX9706912A (es) Inhibidores de protesa retroviral de sulfonamida de hidroxietilamino de amino acido y uso de los mismos.
GEP19991605B (en) Inhibitor, Its Obtaining and Use